Recently, Yanshan Petrochemical medical polypropylene B4908 and B4902 products have passed the safety certification of the national authorities, which means that Sinopec polypropylene medical materials will be officially put on the market, breaking the long-term dependence on imported raw materials in the field of medical consumables.
At present, the annual demand for polyolefin resin in the domestic medical consumables field is over 100,000 tons, and it mainly relies on imports from abroad. Chemical Sales Co., Ltd. has listed the development and promotion of medical polyolefin products as a key research project, and has been marketing Huabei multiple times. The joint Yanshan Petrochemical production technicians provided home testing for the large infusion customers in the country and continuously tracked the trials. They actively communicated with the experts of the national authorities about the details of the experiment. After nearly ten years of research and development and trials, they were finally established on November 15, 2017. The leading company in the industry, Sichuan Kelun Group, successfully tested 100% of its products in line with its production and testing standards. The company successfully passed the safety certification of the national authorities, which signifies that Sinopec has a stepping stone to open the door of the medical material market. North China will comprehensively deploy sales promotion work in the near future, formally cooperate with domestic large infusion customers, and lay the foundation for the next comprehensive replacement of imported materials.